APA (7th ed.) Citation

F, S., & M, D. (2026). Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What's the Current Status? Targeted oncology, 21(1), 63. https://doi.org/10.1007/s11523-025-01189-7

Chicago Style (17th ed.) Citation

F, Segers, and Delforge M. "Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What's the Current Status?" Targeted Oncology 21, no. 1 (2026): 63. https://doi.org/10.1007/s11523-025-01189-7.

MLA (9th ed.) Citation

F, Segers, and Delforge M. "Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What's the Current Status?" Targeted Oncology, vol. 21, no. 1, 2026, p. 63, https://doi.org/10.1007/s11523-025-01189-7.